• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Equipment

CERS:US

3.6100 USD 0.0300 0.82%

As of 09:54:57 ET on 08/22/2014.

Snapshot for Cerus Corp (CERS)

Open: 3.6500 Day's Range: 3.6080 - 3.6700 Volume: 30,600
Previous Close: 3.6400 52wk Range: 3.4800 - 8.0000 1-Yr Rtn: -32.65%

Stock Chart for CERS

No chart data available.
  • CERS:US 3.6300
  • 1D
  • 1M
  • 1Y
3.6400
Interactive CERS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CERS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5238
Est. EPS (USD) (12/2014) -0.5500
Est. PEG Ratio -
Market Cap (M USD) 268.79
Shares Outstanding (M) 74.05
30 Day Average Volume 570,067
Price/Book (mrq) 6.0802
Price/Sale (ttm) 7.1401
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CERS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CERS

Cerus Corporation develops systems designed to enhance the safety of blood transfusions. The Company's systems inactivate pathogens in blood components and inactivate white blood cells, which are responsible for a variety of adverse transfusion reactions. Cerus' platform technologies prevent viral, bacterial, and cellular replication.

William Mariner Greenman "Obi"President/CEOChrystal N MenardChief Legal Officer
Caspar HogeboomPres:Cerus EuropeLaurence M CorashSenior VP/Chief Medical Ofcr/Co-Founder
More Company Profile & Key Executives for CERS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil